Dagnon Terry (CIK 0001760510)

Latest company ownership

Role: Chief Operations Officer
Shares held
653,058
Last filed at
Apr 21, 2023
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Apr 20, 2023 Apr 21, 2023 Outlook Therapeutics, Inc. Chief Operations Officer Sell 20.0 -520,000 -44.33% $590.2K
Jun 21, 2022 Jun 23, 2022 Outlook Therapeutics, Inc. COO Buy 68.8 +10,000 0.86% $10.5K
Dec 6, 2021 Dec 6, 2021 Outlook Therapeutics, Inc. COO Buy 78.8 +25,201 2.21% $34.8K
Dec 3, 2021 Dec 3, 2021 Outlook Therapeutics, Inc. COO Buy 68.8 +10,000 0.89% $14.2K
Feb 23, 2021 Feb 25, 2021 Outlook Therapeutics, Inc. COO Sell 26.3 -15,900 -1.39% $33.2K
Feb 12, 2021 Feb 17, 2021 Outlook Therapeutics, Inc. COO Sell 22.5 -63,700 -5.28% $162.4K